Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose IVIg in CIDP
NCT00001287Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Dec 1990
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by National Institute of Neurological Disorders and Stroke. Started Dec 1990; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT00001287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001287.